title: Oversight for clinical uses of autologous adult stem cells: lessons from international regulations.
abstract: Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited.
authors: Asia Research Institute, National University of Singapore, Singapore 259770, Singapore. Electronic address: tlysaght@nus.edu.sg.
authors: Tamra
authors: T
authors: Lysaght
authors: Ian
authors: I
authors: Kerridge
authors: Douglas
authors: D
authors: Sipp
authors: Gerard
authors: G
authors: Porter
authors: Benjamin J
authors: BJ
authors: Capps
mesh_terms: D000328:Adult; D053687:Adult Stem Cells / Q000637:transplantation*; D006801:Humans; D038622:Internationality; D011364:Professional Practice; D012926:Social Control, Formal; D057905:Stem Cell Research / Q000331:legislation & jurisprudence; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence*; D014182:Transplantation, Autologous